SLC16A2 Gene Allan-Herndon-Dudley Syndrome NGS Genetic DNA Test
Introduction
The SLC16A2 Gene Allan-Herndon-Dudley Syndrome NGS Genetic DNA Test is a revolutionary diagnostic tool designed to identify mutations in the SLC16A2 gene, which are linked to Allan-Herndon-Dudley syndrome, a rare neurological disorder. This test employs Next-Generation Sequencing (NGS) technology to provide a comprehensive analysis of the gene, enabling healthcare professionals to make informed decisions regarding patient management.
What the Test Measures
This genetic test specifically measures variations in the SLC16A2 gene. By analyzing the DNA, the test can detect mutations that may lead to Allan-Herndon-Dudley syndrome, helping in the identification of affected individuals.
Who Should Consider This Test?
This test is particularly recommended for:
- Individuals showing symptoms of neurological disorders.
- Patients with a family history of Allan-Herndon-Dudley syndrome.
- Those advised by a neurologist or genetic counselor for further evaluation.
Benefits of Taking the Test
- Early diagnosis of Allan-Herndon-Dudley syndrome.
- Informed decision-making regarding treatment options.
- Family planning assistance through genetic counseling.
- Access to specialized care tailored to the individual’s needs.
Understanding Your Results
Results from the SLC16A2 Gene Allan-Herndon-Dudley Syndrome NGS Genetic DNA Test will typically be available within 3 to 4 weeks. A genetic counselor or neurologist will help interpret the results, providing guidance on the implications for health and management.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| SLC16A2 Gene Allan-Herndon-Dudley Syndrome NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Booking Information
We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu. For your convenience, we also offer home sample collection services. To book your test or for more information, please call or WhatsApp us at +254711564616.
